Aspen Pharmacare Holdings Limited (APNHY)
OTCMKTS · Delayed Price · Currency is USD
5.75
-0.26 (-4.33%)
Sep 2, 2025, 3:13 PM EDT
Aspen Pharmacare Holdings Market Cap
Aspen Pharmacare Holdings has a market cap or net worth of $2.64 billion as of September 2, 2025. Its market cap has decreased by -53.33% in one year.
Market Cap
2.64B
Enterprise Value
4.27B
Revenue
2.41B
Ranking
n/a
PE Ratio
11.12
Stock Price
$5.75
Market Cap Chart
Since September 22, 1995, Aspen Pharmacare Holdings's market cap has increased from 22.99M to 2.64B, an increase of 11,375.34%. That is a compound annual growth rate of 17.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 1, 2025 | 2.64B | -31.99% |
| Dec 31, 2024 | 3.88B | -21.65% |
| Dec 29, 2023 | 4.95B | 38.74% |
| Dec 30, 2022 | 3.57B | -44.26% |
| Dec 31, 2021 | 6.40B | 64.24% |
| Dec 31, 2020 | 3.90B | 0.35% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.42M |
| Veradigm | 832.17M |
| Elite Pharmaceuticals | 734.61M |
| Tian'an Technology Group | 682.77M |
| Glass House Brands | 655.63M |
| Northwest Biotherapeutics | 448.50M |
| CytoDyn | 376.00M |
| American Oncology Network | 343.87M |